Jonathan Braude is a senior writer in The Deal's London bureau, where he covers M&A and private equity across the U.K. and Europe. He also provides early morning European markets coverage for TheStreet. Prior to joining The Deal, Braude was a writer, political reporter and columnist for the South China Morning Post in Hong Kong and, before that, worked in Brussels, covering the European Union and NATO. He has written for a number of print and broadcasting outlets including the BBC, The Times of London and Jane's Defense Weekly. Braude speaks German, French and Hebrew and reads Spanish and Dutch.
Recent Articles By The Author
AstraZeneca Takeover Chatter Bubbles Up Again After Massive Drug Trial Disappointment
The British pharma company suffers a setback with a lung-cancer drug it touted as a defense against a Pfizer takeover bid three years ago, and could be back in play.
Sky Soars as U.K. Delays Decision on 21st Century Fox Inquiry
U.K. minister says she has not yet had time to consider all responses to her consultation on referring the $15 billion takeover of the satellite broadcaster to the competition regulator.
Stada Arzneimittel Still a Takeover Target Despite $6 Billion Bain and Cinven Bid Collapse
Investors believe Bain and Cinven or a rival consortium could still return for another run at the German generics company, despite the failure of their $6 billion offer.
Parexel to Be Taken Off Market by Private Equity
Pamplona agrees to take the pharmaceutical research company off the Nasdaq for $88.10 per share in a deal valuing the company at $5 billion.
Amazon's Purchase of Whole Foods Hits European Grocers Too
Amazon's blockbuster buy of Whole Foods knocks down supermarket shares in Europe, as the big grocers fear the implications of the U.S. deal in their home markets.